<Q ID=1>
  what is the origin of COVID-19
</Q>

<Q ID=2>
  how does the coronavirus respond to changes in the weather
</Q>

<Q ID=3>
  will SARS-CoV-2 infected people develop immunity? Is cross protection possible?
</Q>

<Q ID=4>
  what causes death from Covid-19?
</Q>

<Q ID=5>
  what drugs have been active against SARS-CoV or SARS-CoV-2 in animal studies?
</Q>

<Q ID=6>
  what types of rapid testing for Covid-19 have been developed?
</Q>

<Q ID=7>
  are there serological tests that detect antibodies to coronavirus?
</Q>

<Q ID=8>
  how has lack of testing availability led to underreporting of true incidence of Covid-19?
</Q>

<Q ID=9>
  how has COVID-19 affected Canada
</Q>

<Q ID=10>
  has social distancing had an impact on slowing the spread of COVID-19?
</Q>

<Q ID=11>
  what are the guidelines for triaging patients infected with coronavirus?
</Q>

<Q ID=12>
  what are best practices in hospitals and at home in maintaining quarantine?
</Q>

<Q ID=13>
  what are the transmission routes of coronavirus?
</Q>

<Q ID=14>
  what evidence is there related to COVID-19 super spreaders
</Q>

<Q ID=15>
  how long can the coronavirus live outside the body
</Q>

<Q ID=16>
  how long does coronavirus remain stable  on surfaces?
</Q>

<Q ID=17>
  are there any clinical trials available for the coronavirus
</Q>

<Q ID=18>
  what are the best masks for preventing infection by Covid-19?
</Q>

<Q ID=19>
  what type of hand sanitizer is needed to destroy Covid-19?
</Q>

<Q ID=20>
  are patients taking Angiotensin-converting enzyme inhibitors (ACE) at increased risk for COVID-19?
</Q>

<Q ID=21>
  what are the mortality rates overall and in specific populations
</Q>

<Q ID=22>
  are cardiac complications likely in patients with COVID-19?
</Q>

<Q ID=23>
  what kinds of complications related to COVID-19 are associated with hypertension?
</Q>

<Q ID=24>
  what kinds of complications related to COVID-19 are associated with diabetes
</Q>

<Q ID=25>
  which biomarkers predict the severe clinical course of 2019-nCOV infection?
</Q>

<Q ID=26>
  what are the initial symptoms of Covid-19?
</Q>

<Q ID=27>
  what is known about those infected with Covid-19 but are asymptomatic?
</Q>

<Q ID=28>
  what evidence is there for the value of hydroxychloroquine in treating Covid-19?
</Q>

<Q ID=29>
  which SARS-CoV-2 proteins-human proteins interactions indicate potential for drug targets. Are there approved drugs that can be repurposed based on this information?
</Q>

<Q ID=30>
  is remdesivir an effective treatment for COVID-19
</Q>

<Q ID=31>
  How does the coronavirus differ from seasonal flu?
</Q>

<Q ID=32>
  Does SARS-CoV-2 have any subtypes, and if so what are they?
</Q>

<Q ID=33>
  What vaccine candidates are being tested for Covid-19?
</Q>

<Q ID=34>
  What are the longer-term complications of those who recover from COVID-19?
</Q>

<Q ID=35>
  What new public datasets are available related to COVID-19?
</Q>

<Q ID=36>
  What is the protein structure of the SARS-CoV-2 spike?
</Q>

<Q ID=37>
  What is the result of phylogenetic analysis of SARS-CoV-2 genome sequence?
</Q>

<Q ID=38>
  What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases?
</Q>

<Q ID=39>
  What is the mechanism of cytokine storm syndrome on the COVID-19?
</Q>

<Q ID=40>
  What are the observed mutations in the SARS-CoV-2 genome and how often do the mutations occur?
</Q>

<Q ID=41>
  What are the impacts of COVID-19 among African-Americans that differ from the rest of the U.S. population?
</Q>

<Q ID=42>
  Does Vitamin D impact COVID-19 prevention and treatment?
</Q>

<Q ID=43>
  How has the COVID-19 pandemic impacted violence in society, including violent crimes?
</Q>

<Q ID=44>
  How much impact do masks have on preventing the spread of the COVID-19?
</Q>

<Q ID=45>
  How has the COVID-19 pandemic impacted mental health?
</Q>

<Q ID=46>
  what evidence is there for dexamethasone as a treatment for COVID-19?
</Q>

<Q ID=47>
  what are the health outcomes for children who contract COVID-19?
</Q>

<Q ID=48>
  what are the benefits and risks of re-opening schools in the midst of the COVID-19 pandemic?
</Q>

<Q ID=49>
  do individuals who recover from COVID-19 show sufficient immune response, including antibody levels and T-cell mediated immunity, to prevent re-infection?
</Q>

<Q ID=50>
  what is known about an mRNA vaccine for the SARS-CoV-2 virus?
</Q>

